178 related articles for article (PubMed ID: 17965964)
21. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
[TBL] [Abstract][Full Text] [Related]
22. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
23. Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women.
Jones G; White C; Nguyen T; Sambrook PN; Kelly PJ; Eisman JA
Osteoporos Int; 1996; 6(3):233-9. PubMed ID: 8783298
[TBL] [Abstract][Full Text] [Related]
24. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.
Chiloiro S; Mormando M; Bianchi A; Giampietro A; Milardi D; Bima C; Grande G; Formenti AM; Mazziotti G; Pontecorvi A; Giustina A; De Marinis L
Endocrine; 2018 Feb; 59(2):449-453. PubMed ID: 28836162
[TBL] [Abstract][Full Text] [Related]
26. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis.
Barake M; Arabi A; Nakhoul N; El-Hajj Fuleihan G; El Ghandour S; Klibanski A; Tritos NA
Endocrine; 2018 Jan; 59(1):39-49. PubMed ID: 29030774
[TBL] [Abstract][Full Text] [Related]
27. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
28. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
29. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
[TBL] [Abstract][Full Text] [Related]
30. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
[TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.
Barake M; Klibanski A; Tritos NA
J Clin Endocrinol Metab; 2014 Mar; 99(3):852-60. PubMed ID: 24423364
[TBL] [Abstract][Full Text] [Related]
32. Monocentric study of 112 consecutive patients with childhood onset GH deficiency around and after transition.
Courtillot C; Baudoin R; Du Souich T; Saatdjian L; Tejedor I; Pinto G; Léger J; Polak M; Golmard JL; Touraine P;
Eur J Endocrinol; 2013 Nov; 169(5):587-96. PubMed ID: 23939920
[TBL] [Abstract][Full Text] [Related]
33. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
34. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients.
Mormando M; Chiloiro S; Bianchi A; Giampietro A; Angelini F; Tartaglione L; Nasto L; Milardi D; Formenti AM; Giustina A; De Marinis L
Clin Endocrinol (Oxf); 2016 Nov; 85(5):717-724. PubMed ID: 27437620
[TBL] [Abstract][Full Text] [Related]
36. Influence of growth hormone on accretion of bone mass.
Monson JP; Drake WM; Carroll PV; Weaver JU; Rodriguez-Arnao J; Savage MO
Horm Res; 2002; 58 Suppl 1():52-6. PubMed ID: 12373015
[TBL] [Abstract][Full Text] [Related]
37. Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty.
Çetinkaya S; Poyrazoğlu Ş; Baş F; Ercan O; Yıldız M; Adal E; Bereket A; Abalı S; Aycan Z; Erdeve ŞS; Berberoğlu M; Şıklar Z; Tayfun M; Darcan Ş; Mengen E; Bircan İ; Jones FMÇ; Şimşek E; Papatya ED; Özbek MN; Bolu S; Abacı A; Büyükinan M; Darendeliler F
J Pediatr Endocrinol Metab; 2018 Jan; 31(2):175-184. PubMed ID: 29353264
[TBL] [Abstract][Full Text] [Related]
38. [Vertebral deformities and bone density in the elderly; the ERGO Study (Erasmus Rotterdam Health and the Elderly). ERGO Study Group].
Burger H; van Daele PL; Hofman A; Schütte HE; Birkenhäger JC; Pols HA
Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2092-6. PubMed ID: 7477568
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.
Nishizawa H; Iguchi G; Murawaki A; Fukuoka H; Hayashi Y; Kaji H; Yamamoto M; Suda K; Takahashi M; Seo Y; Yano Y; Kitazawa R; Kitazawa S; Koga M; Okimura Y; Chihara K; Takahashi Y
Eur J Endocrinol; 2012 Jul; 167(1):67-74. PubMed ID: 22535644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
